Transient Responses to NOTCH and TLX1/HOX11 Inhibition in T-Cell Acute Lymphoblastic Leukemia/Lymphoma

To improve the treatment strategies of T-cell acute lymphoblastic leukemia/lymphoma (T-ALL), further efforts are needed to identify therapeutic targets. Dysregulated expression of HOX-type transcription factors occurs in 30–40% of cases of T-ALL. TLX1/HOX11 is the prototypical HOX-type transcription...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakowski, Lesley A., Lehotzky, Erica A., Chiang, Mark Y.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033898/
https://www.ncbi.nlm.nih.gov/pubmed/21326611
http://dx.doi.org/10.1371/journal.pone.0016761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033898/
https://www.ncbi.nlm.nih.gov/pubmed/21326611
http://dx.doi.org/10.1371/journal.pone.0016761

Ejemplares similares